The UK Biobank data exposure highlights a growing risk in modern health research: sensitive data is not only vulnerable to breaches, but to systemic leakage through normal scientific practices. This raises urgent...read more
Category - Data analysis/bioinformatics
From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand
TL;DR 2025 shifted healthcare from experimentation to execution AI moved from tools to infrastructure 2026 will reward disciplined execution over vision Why this matters for precision medicine + generative AI This...read more
Abbott to acquire Exact Sciences
• Acquisition adds a new growth vertical to Abbott’s already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments•...read more
Why Are We Still Talking About Data Infrastructure for Life Sciences in 2025?
“In my twenty-five years in the Life Sciences industry, I’ve observed countless organizations adopt, revise, dismantle, and rebuild their data infrastructure.” While the rapid advancements of data technology certainly...read more
